SYK
Stryker Corporation · Healthcare
Insiders bought $27K of Stryker Corporation in the last 12 months
1 insider bought on 1 day.
SYK over the last year
Largest buyers, last 12 months
SYK after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Congress
Members reported 59 trades in SYK since 2023.
Every filing
270 insider filings since 2016, newest first
William E Berry Jr · VP, Corporate Controller
M Kathryn Fink · VP and CHRO
Glenn S Boehnlein · VP and CFO
Katherine Ann Owen · VP, Strategy, IR
Lonny J Carpenter · Group Pres
Katherine Ann Owen · VP, Strategy, IR
Glenn S Boehnlein · VP and CFO
Katherine Ann Owen · VP, Strategy, IR
Kevin Lobo · Chair and CEO
Yin C Becker · VP, Comm., Public Affairs
David Floyd · Group Pres
Yin C Becker · VP, Comm., Public Affairs
Katherine Ann Owen · VP, Strategy, IR
Graham A Mclean · Pres, Asia-Pacific
Lonny J Carpenter · Group Pres
Howard E Cox Jr · Director
William E Berry Jr · VP, Corporate Controller
Louise Francesconi · Director
Graham A Mclean · Pres, Asia-Pacific
Lonny J Carpenter · Group Pres
Graham A Mclean · Pres, Asia-Pacific
Lonny J Carpenter · Group Pres
David Floyd · Group Pres, Orthopaedics
David Floyd · Group Pres, Orthopaedics
Timothy J Scannell · Group Pres
Kevin Lobo · Chair and CEO
Howard E Cox Jr · Director
Yin C Becker · VP, Comm., Public Affairs
Louise Francesconi · Director
Yin C Becker · VP, Comm., Public Affairs
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Ronda E Stryker · Director
Kevin Lobo · Chair and CEO
Ronda E Stryker · Director
Ronda E Stryker · Director
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.